2024-03-21 11:55:10 ET
Summary
- HealthEquity has experienced impressive growth in revenue and EBITDA over the past decade.
- In the most recent quarter, the company reported a beat on both revenues and EPS as a result of margin expansion and growth in HSA accounts and assets under management.
- The company's latest acquisition has cemented it as the largest provider of HSAs in the United States as it continues to grow market share.
- As HealthEquity has delivered strong growth in earnings and profitability over the years while the stock has remained flat, shares finally look like a buy.
Introduction
Read the full article on Seeking Alpha
For further details see:
HealthEquity: Multiple Compression Has Finally Made It A Buy